- Home
- DUOT vs OBIO Comparison
DUOT vs OBIO Comparison
Compare DUOT & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUOT
- OBIO
- Stock Information
- Founded
- DUOT 1990
- OBIO 2017
- Country
- DUOT United States
- OBIO United States
- Employees
- DUOT N/A
- OBIO N/A
- Industry
- DUOT Computer Software: Prepackaged Software
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- DUOT Technology
- OBIO Health Care
- Exchange
- DUOT Nasdaq
- OBIO Nasdaq
- Market Cap
- DUOT 180.9M
- OBIO 172.1M
- IPO Year
- DUOT N/A
- OBIO N/A
- Fundamental
- Price
- DUOT $9.87
- OBIO $5.22
- Analyst Decision
- DUOT Strong Buy
- OBIO Strong Buy
- Analyst Count
- DUOT 2
- OBIO 4
- Target Price
- DUOT $12.75
- OBIO $13.67
- AVG Volume (30 Days)
- DUOT 340.7K
- OBIO 359.3K
- Earning Date
- DUOT 11-12-2025
- OBIO 11-10-2025
- Dividend Yield
- DUOT N/A
- OBIO N/A
- EPS Growth
- DUOT N/A
- OBIO N/A
- EPS
- DUOT N/A
- OBIO N/A
- Revenue
- DUOT $19,026,308.00
- OBIO $2,818,000.00
- Revenue This Year
- DUOT $292.26
- OBIO $31.43
- Revenue Next Year
- DUOT $43.21
- OBIO $10.87
- P/E Ratio
- DUOT N/A
- OBIO N/A
- Revenue Growth
- DUOT 159.00
- OBIO 6.46
- 52 Week Low
- DUOT $3.84
- OBIO $2.20
- 52 Week High
- DUOT $11.23
- OBIO $6.30
- Technical
- Relative Strength Index (RSI)
- DUOT 57.43
- OBIO 69.74
- Support Level
- DUOT $8.10
- OBIO $4.15
- Resistance Level
- DUOT $9.53
- OBIO $4.02
- Average True Range (ATR)
- DUOT 0.79
- OBIO 0.42
- MACD
- DUOT -0.01
- OBIO 0.09
- Stochastic Oscillator
- DUOT 68.94
- OBIO 89.05
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.